Abstract
During a 7-month period 33 patients (20 with primary open-angle glaucoma and 13 with suspected glaucoma) were treated with guanethidine 3% and adrenaline 0.5% in 1 eyedrop twice daily. The previous therapy was discontinued and the aim of the trial was to treat the patients with GA alone. There was an average decrease in intraocular pressure of 10.8 mmHg or 37.5% for the whole group (including 5 patients with additional therapy). In eyes with an average IOP in a day-curve without medication equal to or higher than 28 mmHg we found a decrease of 44.6% or 14.4 mmHg, and in eyes with an average IOP without medication between 21 and 28 mmHg a decrease of 30.4% or 7.6 mmHg. With GA alone the IOP was 3.3 to 3.9 mmHg lower than on the previous therapy (P less than 0.05); 46% of the eyes without additional therapy had all IOPs lower than 22 mmHg and 74% of the eyes had IOPs lower than 22 mmHg except 1 with a peak lower or equal to 25 mmHg 3 hours after application. This peak 3 hours after application indicates that GA has a biphasic action and was significant at the 0.5% level. Red eyes and slight ptosis were no problem for most patients. Patients found it very convenient to administer GA only twice daily.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonomi L., DiComite P. Outflow facility after guanethidine sulfate administration. Arch Ophthalmol. 1967 Sep;78(3):337–340. doi: 10.1001/archopht.1967.00980030339014. [DOI] [PubMed] [Google Scholar]
- Crombie A. L. Adrenergic supersensitization as a therapeutic tool in glaucoma. Trans Ophthalmol Soc U K. 1974 Jul;94(2):570–572. [PubMed] [Google Scholar]
- Gloster J. Guanethidine and glaucoma. Trans Ophthalmol Soc U K. 1974 Jul;94(2):573–577. [PubMed] [Google Scholar]
- Jones D. E., Norton D. A., Davies D. J. Low dosage combined adrenaline-guanethidine formulations in the management of chronic simple glaucoma. Trans Ophthalmol Soc U K. 1977 Apr;97(1):192–195. [PubMed] [Google Scholar]
- KUTSCHERA E. [Clinical experience with Ismelin]. Klin Monbl Augenheilkd Augenarztl Fortbild. 1961 Sep;139:234–241. [PubMed] [Google Scholar]
- Nagasubramanian S., Tripathi R. C., Poinoosawmy D., Gloster J. Low centration guanethidine and adrenaline therapy of glaucoma. A preliminary report. Trans Ophthalmol Soc U K. 1976 Apr;96(1):179–183. [PubMed] [Google Scholar]
- OOSTERHUIS J. A. Guanethidine (Ismelin) in ophthalmology. I. Observations in rabbits. Arch Ophthalmol. 1962 May;67:592–599. doi: 10.1001/archopht.1962.00960020592013. [DOI] [PubMed] [Google Scholar]
- Paterson G. D., Paterson G. Drug therapy of glaucoma. Br J Ophthalmol. 1972 Mar;56(3):288–294. doi: 10.1136/bjo.56.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Romano J. Use of guanethidine 5% and adrenaline 1% in the treatment of severe open angle glaucoma. Trans Ophthalmol Soc U K. 1977 Apr;97(1):196–201. [PubMed] [Google Scholar]
- Roth J. A. Guanethidine and adrenaline used in combination in chronic simple glaucoma. Br J Ophthalmol. 1973 Jul;57(7):507–510. doi: 10.1136/bjo.57.7.507. [DOI] [PMC free article] [PubMed] [Google Scholar]